FindTrial
Sign In

Preoperative evaluation of axillary lymph node status in breast cancer based on ultrasound radiomics and pathomics

Preoperative evaluation of axillary lymph node status in breast cancer based on ultrasound radiomics and pathomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126532
Enrollment
Unknown
Registered
2026-06-10
Start date
2024-11-01
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive breast cancer

Interventions

axillary lymph node metastasis group:None
Axillary lymph node non-metastasis group:None

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women with suspected breast cancer detectable by ultrasound; 2. Ultrasound-guided breast biopsy CNB within one day of breast ultrasound; 3. Breast surgery within 1-2 weeks after CNB.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of ipsilateral breast cancer and preoperative systemic therapy or radiotherapy; 2. Maximum tumor diameter beyond the measurable range of ultrasound transducer (clinical T3-4 tumors); 3. Benign lesions or carcinoma in situ diagnosed by CNB or surgical pathology; 4. Immunohistochemical results for ER/PR status in surgical specimens lacking; 5. Missing US image or WSI.

Design outcomes

Primary

MeasureTime frame
Sensitivity;specificity;positive predictive value and negative predictive value;—

Countries

China

Contacts

Public ContactSun Litao

Zhejiang Provincial People's Hospital

litaosun1971@sina.com+86 151 5811 0363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026